Correction: Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.

Correction: Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.

[This corrects the article DOI: 10.1371/journal.pone.0246191.].

Bibliographic Details
Main Authors:	Euri Seo, Eun Seok Choi, Jung Hwa Kim, Hyery Kim, Kyung-Nam Koh, Ho Joon Im, Jina Lee
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0294486&type=printable

Similar Items

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
by: Hyeyoung Lee, et al.
Published: (2017-01-01)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
by: Paul V. Lehmann, et al.
Published: (2012-04-01)

Development of an EliSPOT assay for detection of CMV-specific immune response
by: Maria Elena Terlizzi, et al.
Published: (2010-06-01)

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells
by: Helen M McGuire, et al.
Published: (2020-01-01)

Cytomegalovirus (CMV) Infection and Latency
by: Christine M. O’Connor
Published: (2021-03-01)

Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation
by: Ian Pang, et al.
Published: (2022-01-01)

Cytomegalovirus (CMV) epitope-specific CD4(+) T cells are inflated in HIV(+) CMV(+) subjects
by: Abana, CO, et al.
Published: (2017)

Efficacy Assessment of Cytomegalovirus-Specific Immunoglobulins for the Management of CMV Reactivation in High-Risk Hematopoietic Stem Cell Transplant Recipients
by: Ignas Gaidamavičius, et al.
Published: (2024-05-01)

P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
by: D. Beauvais, et al.
Published: (2022-06-01)

Monitoring of cytomegalovirus (CMV) infection in solid organ transplant recipients: quantitation of CMV DNAemia by two real-time polymerase chain reaction assays
by: Angela Chiereghin, et al.
Published: (2016-10-01)

Droplet Digital PCR (ddPCR) Does Not Enhance the Sensitivity of Detection of Cytomegalovirus (CMV) DNA in Newborn Dried Blood Spots Evaluated in the Context of Newborn Congenital CMV (cCMV) Screening
by: Nelmary Hernandez-Alvarado, et al.
Published: (2023-12-01)

Detection of cytomegalovirus (CMV) by digital PCR in stool samples for the non-invasive diagnosis of CMV gastroenteritis
by: Jia Gu, et al.
Published: (2022-11-01)

Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
by: Heinrike Wilkens, et al.
Published: (2016-01-01)

Incidence of ophthalmic manifestations in congenital cytomegalovirus (CMV)
by: Jennifer L. Rossen, et al.
Published: (2025-01-01)

Cytomegalovirus infection of brain tumors and CMV immunotherapy
by: Mykola I. Lisianyi, et al.
Published: (2022-09-01)

CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Rafael de la Camara
Published: (2016-06-01)

How Do Donor-recipient CMV Serostatus and Post-hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
by: Mohammad Vaezi, et al.
Published: (2016-10-01)

The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
by: Dolores Grosso, et al.
Published: (2019-09-01)

Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
by: Isabelle P. Lodding, MD, et al.
Published: (2018-06-01)

Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells
by: Sarah E. Jackson, et al.
Published: (2017-06-01)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
by: Swetha Pinninti, et al.
Published: (2023-10-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
by: Monica Miele, et al.
Published: (2021-03-01)

Combined Analysis of Early CD4<sup>+</sup> T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation
by: Saskia Leserer, et al.
Published: (2021-11-01)

Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients
by: Ann-Kristin Traska, et al.
Published: (2024-04-01)

Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update
by: Katya Prakash, et al.
Published: (2021-05-01)

Prevalence of asymptomatic cytomegalovirus (CMV) infection in newborns in northeast Florida
by: Rana Alissa, et al.
Published: (2024-01-01)

Human cytomegalovirus (CMV) dysregulates neurodevelopmental pathways in cerebral organoids
by: Ece Egilmezer, et al.
Published: (2024-03-01)

Diagnostic Utility of Cytomegalovirus (CMV) DNA Quantitation in Ulcerative Colitis
by: Sema Esen, et al.
Published: (2024-04-01)

Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection
by: Mark R. Schleiss, et al.
Published: (2020-09-01)

Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection
by: Cui Xiaohong, et al.
Published: (2008-04-01)

CMV seroconversion in pregnants and the incidence of congenital CMV infection
by: Ali Satilmiş, et al.
Published: (2007-01-01)

Surveillance over cytomegalovirus (CMV) reactivation following hematopoietic stem cell transplantation: a single-center experience
by: Zhivka Stoykova, et al.
Published: (2024-12-01)

Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation
by: Yu Wang, et al.
Published: (2024-01-01)

CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantation
by: Melissa Panesso, et al.
Published: (2023-07-01)

Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse
by: Xiao-Hua Luo, et al.
Published: (2023-02-01)

A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
by: Lakshin Kumar, et al.
Published: (2023-08-01)

P1334: THE IMPACT OF IMMUNOSUPPRESSION ON RECONSTITUTION OF CMV-SPECIFIC T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: A. Dmitrova, et al.
Published: (2022-06-01)

Prevalence of cytomegalovirus (CMV) infection among infants and correlation between cmv pcr with clinical outcomes in Hospital Universiti Sains Malaysia (HUSM)
by: Norjihan, Abdul Hamid
Published: (2020)